1. Executive Summary
2. Research Methodology
3. Electrophysiology/ Atrial Fibrillation Ablation
3.1 Electrophysiology: Overview
3.2 Indications
3.2.1 Atrial Fibrillation
3.2.2 Atrial Flutter
3.2.3 Atrioventricular Nodal Reentry Tachycardia (AVNR)
3.2.4 Wolff-Parkinson-White Syndrome (WPW)
3.2.5 Others
3.3 Ablation
3.3.1 Overview
3.3.2 Types of Procedure
3.4 Atrial Fibrillation: Overview
3.4.1 Classification of Atrial Fibrillation
3.4.2 Symptoms & Diagnosis of Atrial Fibrillation
3.4.3 Treatment of Atrial Fibrillation
4. Market Analysis
4.1 Market Sizing (Actual & Forecasted)
4.1.1 Market Size by Value (Actual & Forecasted)
4.1.2 Market Size by Volume (Actual & Forecasted)
4.2 Market Share Analysis
4.2.1 Market Share by Products
4.2.2 Market Share by Application
4.2.3 Market Share by Region
5. Global Electrophysiology Market Segmentation
5.1 Market Segmentation by Products
5.1.1 EP Ablation Catheters
5.1.2 EP Diagnostic Catheter
5.1.3 Cardiac Monitors
5.2 Market Segmentation by Application
5.2.1 EP Monitoring Devices
5.2.2 EP Treatment Devices
6. Market Dynamics
6.1 Industry Trends & Developments
6.1.1 FIRM-Guided Ablation for Atrial Fibrillation
6.1.2 Mergers & Acquisitions
6.1.3 Advent of New Oral Anticoagulants (NOACs)
6.2 Growth Drivers
6.2.1 Higher Prevalence of Atrial Fibrillation
6.2.3 Rise in Number of Hypertension Patients
6.2.4 Increasing Incidence of Valvular Heart Disease
6.2.5 Growing Geriatric Population
6.2.6 Increasing Demand for Minimally Invasive Procedures
6.3 Challenges
6.3.1 Stringent Regulatory Approval
6.3.2 Reimbursement Issues
6.3.3 Dearth of Skilled Professionals
6.3.4 Treatment Skewed towards Pharmaceutical Intervention
7. Competitive Landscape
7.1 Therapeutic Pipeline
7.2 Market Share by Competitors
7.2.1 EP Market Share by Competitors
7.2.2 Market Share by Drugs
8. Company Profile
8.1 Medtronic Plc
8.2 Biosense Webster, Inc.
8.3 Abbott Laboratories
8.4 Boston Scientific Corporation